Their first product Dermacann is due to be released to market early this year and revenue will flow from that but CPAT01 is the badboy. Think I have all that right. Been a holder for a long time and many announcements have been made.
CP1 Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held